Less than twenty years ago, Venezuela was Latin America's wealthiest nation.  In the terrifyingly brief…
CFIF on Twitter CFIF on YouTube
CFIF Letter to White House: Keep Targeting Rogue Venezuelan Regime, But Protect U.S. Enterprises Operating There

Less than twenty years ago, Venezuela was Latin America's wealthiest nation.  In the terrifyingly brief time since then, however, the rogue socialist regimes of Hugo Chavez and now his successor Nicolas Maduro have reduced it to a dystopian rubble more akin to starving Cuba.  For that, the United States justifiably isolates and targets the Maduro regime for its ongoing corruption, theft and human rights abuses.

Amid that effort, however, we must also protect vulnerable American companies that have conducted business in Venezuela since long before the Chavez and Maduro regimes.  By granting those American businesses specific waivers to continue operations, we protect them from suffering asset seizure at the hands of Maduro and his cronies.  The alternative of denying that latitude would…[more]

October 29, 2020 • 10:38 AM

Liberty Update

CFIFs latest news, commentary and alerts delivered to your inbox.
Jester's CourtroomLegal tales stranger than stranger than fiction: Ridiculous and sometimes funny lawsuits plaguing our courts.
Home Press Room CFIF Urges “No” Vote on H.R. 3, Speaker Pelosi’s Destructive Drug Pricing Bill
CFIF Urges “No” Vote on H.R. 3, Speaker Pelosi’s Destructive Drug Pricing Bill Print
Wednesday, December 11 2019

ALEXANDRIA, VA – The U.S. House of Representatives is scheduled to vote on Speaker Nancy Pelosi's H.R. 3, the "Lower Drug Costs Now Act of 2019."  The Center for Individual Freedom ("CFIF") is urging all House Members to vote "No," as the legislation would, among other significant issues, stifle innovation, limit access to life-saving medications and reduce projected gains in life-expectancy for all Americans. What follows is a statement by CFIF President Jeffrey Mazzella:

"CFIF unambiguously opposes H.R. 3, the so-called 'Lower Drug Costs Now Act of 2019'.

"Contrary to its misleading title, the primary effect of Pelosi’s bill wouldn’t be to lower drug costs, but to severely threaten Americans’ access to healthcare and life-saving medicines by imposing foreign price controls, compulsory arbitration with government bureaucrats, a complete restructuring of the popular Medicare Part D program and what amounts to a retroactive tax on hundreds of the most commonly used medicines in America.

"America currently claims the world’s most innovative pharmaceutical industry, accounting for two-thirds of all new lifesaving and life-improving drugs globally.  But by importing price controls from foreign nations – which ignore drug patents to extort compliance – American consumers would suffer the same negative consequences that those nations’ consumers do:  unavailability of those critical lifesaving and life-improving drugs.

"Indeed, the Congressional Budget Office ('CBO') itself determined that H.R. 3 would reduce the number of new medicines introduced into the market, and the Council of Economic Advisers (‘CEA’) found that the bill’s price control mechanisms would impact fully one-third of all medicines under development.  The CEA also forecasts that H.R. 3 would reduce current expected U.S. life expectancy improvements over the coming decade by 25%.

"The United Nations World Health Organization ('WHO') has similarly acknowledged that price controls suffocate innovation and delay the arrival of new drugs, or deny them entirely.  That's why the nations pursuing that destructive path receive a mere fraction of the new pharmaceuticals that Americans are able to access, which also explains why America outpaces those countries in terms of cancer survival rates and other benefits.  Pelosi's bill would also jeopardize nearly $1 trillion of pharmaceutical investment, research and development.

"This is all far too high a price for Americans to pay on behalf of Nancy Pelosi's big-government drug pricing scheme. CFIF therefore opposes H.R. 3 in the strongest terms, applauds Members of Congress who have already voiced opposition to it and urges all House Members to vote 'No.'"

CFIF is a constitutional and free market advocacy organization with over 300,000 supporters and activists nationwide. 

###

Related Articles :
Question of the Week   
Currently, U.S. Daylight Saving Time ends annually on which of the following?
More Questions
Quote of the Day   
 
"Twitter CEO Jack Dorsey lied to Congress on Tuesday during a Senate hearing focused on Big Tech's content moderation policies when he claimed that his social media company has never censored President Donald Trump.'Just to be clear, we have not censored the president,' Dorsey said in response to Sen. Marsha Blackburn of Tennessee. 'We have not taken the tweets down that you're referencing. We have…[more]
 
 
—Jordan Davidson, The Federalist
— Jordan Davidson, The Federalist
 
Liberty Poll   

Okay, time to outguess the pollsters without all the folderol. Who's going to win? The clock is ticking.